Search

Search results

Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Is Less More?

… Text Figures & Tables References Article Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Is Less … 0 Downloads: 1 Abstract The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary …

Type:

Article

Controversies in Antiplatelet and Anticoagulation Therapy in Patients Presenting with Acute Coronary Syndrome

… Text Figures & Tables References Article Controversies in Antiplatelet and Anticoagulation Therapy in Patients Presenting with Acute Coronary Syndrome … care of the ACS patient are discussed: (1) choice initial antiplatelet and anticoagulant combination; (2) decision to …

Type:

Article

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention

… inhibitor-based monotherapy after a short period of dual antiplatelet therapy is emerging as a plausible strategy to decrease … bleeding events in high-risk patients receiving dual antiplatelet therapy after percutaneous coronary …

Type:

Article

Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement

… evidence supporting the current guideline-mediated therapy for antithrombotics post-TAVR. In this article, the … therapy in patients undergoing TAVR, studies evaluating antiplatelet regimens, and studies evaluating the use of … also offer a potential link between thrombocytopenia and antiplatelet treatments in patients undergoing TAVR. Keywords …

Type:

Article

Attending to Links in the Safety Chain for Drug-Eluting Stents

… thrombosis in this study was premature discontinuation of antiplatelet therapy (hazard ratio (HR) 89.78, p …

Type:

Article

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention

… & Tables References Article Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention … are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, …

Type:

Article

Attending to Links in the Safety Chain for Drug-Eluting Stents

… thrombosis in this study was premature discontinuation of antiplatelet therapy (hazard ratio (HR) 89.78, p …

Type:

Article

Platelet Function Testing in High-risk Coronary Artery Disease Patients - An Update

… testing , platelet reactivity , coronary artery disease , antiplatelet therapy , Disclosure: The author has no conflicts of interest … laboratories and intensive cardiac units is to guide antiplatelet therapy to the optimal dose for the prevention …

Type:

Article

Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

… the physician is challenged with decisions regarding which antiplatelet regimen to administer. The open-label, … treated with PCI. At 1-year follow-up both dual and triple therapy with rivaroxaban were superior to triple therapy with … the physician is challenged with decisions regarding what antiplatelet regimen to administer. Although it is estimated …

Type:

Article

Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

… Figures & Tables References Article Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized … Regiment: Safety and Efficacy of 6 Months Dual Antiplatelet Therapy after Drug-Eluting Stenting (ISAR-SAFE) … late stent thrombosis. For example, in the Prolonging Dual Antiplatelet Treatment After Grading Stent-induced Intimal …

Type:

Article